Futurists can dish out some exciting and downright scary visions for the future of machines and science. Will consider current and future advances in the physical and information sciences, engineering and mathematics by means of the lens of current and future national and international safety dynamics, to reveal potentially desirable avenues of technological pursuit and to catalyze non-obvious synergies among participants. From 2009-2011, she served as a senior policy advisor on emerging technologies issues in the Workplace of the Commissioner at the U.S. Food & Drug Administration. Cyberpunk 2020 is a good old pen and paper RPG (Part Playing Game) and one of the very best.
A member of the National Academy of Science’s Institute of Medicine (IOM) and Committee on Science, Technology and Law, she co-chaired the committee that drafted the National Academies’ Suggestions for Embryonic Stem Cell Analysis. He is also head of the Laptop Vision Group at the International Pc Science Institute (ICSI) affiliated with the university.
Jeff Gore joined the Physics Division at the Massachusetts Institute of Technology (MIT) as an Assistant Professor in January 2010 following spending the preceding three years in the Department as a Pappalardo Fellow working with Alexander van Oudenaarden. In 2004, Raskar received the TR100 Award from Technology Evaluation, which recognizes best young innovators below the age of 35, and in 2003, the International Indus Technovator Award, instituted at MIT to recognize the top 20 Indian technologies innovators worldwide. A fourth book about the Navy’s historic role in the U.S. space system is scheduled for publication in 2016.
Revolutionary advances in the biological sciences promise a host of new capabilities, from programmable microbes to brain-machine interfaces that interpret and right disruptive neural wave types or enable direct manage of devices via thought alone. From 2009 to 2011, she served as a senior policy advisor on emerging technology problems in the Workplace of the Commissioner at the U.S. Food & Drug Administration. For almost 30 years, Ivan Amato has chronicled the story of some of the most influential drivers of our instances: science and technology.
A member of the National Academy of Science’s Institute of Medicine (IOM) and Committee on Science, Technologies and Law, she co-chaired the committee that drafted the National Academies’ Recommendations for Embryonic Stem Cell Research. From 2012-2013, he served as the Assistant Director for Health-related Innovation of the Science Division at the White Property Office of Science and Technologies Policy. He has been a correspondent for National Public Radio and contributed to media outlets such as Time, Fortune, the Washington Post, Nature, Technology Review and the Discovery Channel.